6-Methyl-2,4-dioxo-3-phenyl-1h,2h,3h,4h-furo[2,3-d]pyrimidine-5-carboxylic acid, 97%, 50mg

AKT Inhibitor VIII, >97.0%(HPLC), 25mg

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(4-nitrobenzyl)pyrrolidine-2-carboxylic acid, 95.0%, 250mg

tert-Butyl ((S)-1-amino-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)carbamate, 100mg

N-(3-cyanophenyl)-N-(4-methoxyphenyl)amine, 97.0%, 1g

tert-Butyl 4,4-difluoro-3-oxopiperidine-1-carboxylate, 97%, 1g

N-Bocamino-cyano-acetic acid ethyl ester, 98.0%, 5g

1-tert-Butyl 2-methyl (2S,4R)-4-chloropyrrolidine-1,2-dicarboxylate, 98%, 5g

4-(DIBENZYLAMINO)BUTAN-2-ONE, 95.0%, 1g

6-Bromo-2-methylthiazolo[5,4-b]pyridine, 95.0%, 5g

N-Acetyl-4'-tetrahydropyranylglycine, 97.0%, 250mg

TERT-BUTYL N-[(3R,4R)-3-FLUOROPIPERIDIN-4-YL]CARBAMATE, 95.0%, 250mg

Acetic acid, 2-[2-[4-[(R)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, hydrochloride (1:2), 98%, 1g